Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels

作者: Allen B. Reitz , Virginia L. Smith-Swintosky

DOI:

关键词:

摘要: The present invention is a method for the glucose related disorders and lipid comprising administering to subject in need thereof therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives formula (I) (II) as herein defined. further directed methods treatment co-therapy with an anti-diabetic agent, anti-lipid agent and/or anti-obesity agent.

参考文章(187)
Kenneth Emancipator, Laboratory Diagnosis and Monitoring of Diabetes Mellitus American Journal of Clinical Pathology. ,vol. 112, pp. 665- 674 ,(1999) , 10.1093/AJCP/112.5.665
Pol Vilain, Gilbert Mouzin, Henri Cousse, Preparation of 3-amino-1-[(1,4-benzodioxan)-2-yl-methoxy]-2-propanols ,(1983)
Barbara A. Ramlo-Halsted, Steven V. Edelman, THE NATURAL HISTORY OF TYPE 2 DIABETES: Implications for Clinical Practice Primary Care. ,vol. 26, pp. 771- 790 ,(1999) , 10.1016/S0095-4543(05)70130-5
Erwin K. Kastrup, James R. Boyd, Sally Gifford, Drug facts and comparisons Facts and Comparisons Division, J.B. Lippincott. ,(1977)